{"text": "$UNH Barclays analyst Steve Valiquette raised the firm's price target on UnitedHealth to $365 from $322 and keeps an Overweight rating on the shares ahead of the company's Q3 results. The analyst sees greater visibility on earnings due to reduced membership risk.", "author_id": "12443962", "created_at": "2020-10-13T12:51:16.000Z", "id": "1315998537973411842"}
{"created_at": "2020-10-13T20:58:01.000Z", "author_id": "4377951136", "text": "RT @eWhispers: #earnings season starts Tuesday \n\nhttps://t.co/lObOE0dgsr \n\n$JPM $JNJ $C $BAC $PGR $DAL $BLK $UNH $WFC $GS $FAST $APHA $WBA\u2026", "id": "1316121032428793857"}
{"created_at": "2020-10-13T22:24:04.000Z", "author_id": "31424695", "text": "RT @eWhispers: #earnings scheduled before the market opens on Wednesday \n\nhttps://t.co/lObOE0uRjZ \n\n$BAC $UNH $WFC $GS $PGR $PNC $ASML $USB\u2026", "id": "1316142690246033408"}
{"text": "LONG  100 $MSFT 100 $FB 80 $JPM 60 $V 100 $PG 100 $UNH 90 $PFE 60 $HD 100 $CMCSA 50 $PEP 100 $NFLX 100 $C 70 $MCD 100 $WMT 60 $MDT 100 $PYPL 50 $MMM 50 $AVGO 70 $ABBV 100 $HON 50 $IWM 50 $EEM 100 $FXI 100 $EWH 100 $DBA 100 $BKLN 100 $XLV 100 $HBI 50 $KHC", "author_id": "1183943943852974081", "created_at": "2020-10-13T10:00:23.000Z", "id": "1315955536089608193"}
